Related references
Note: Only part of the references are listed.Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
Pal Brasnyo et al.
BRITISH JOURNAL OF NUTRITION (2011)
A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
Allan D. Sniderman et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
ESC/EAS GUIDELINES ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2011)
Concordance between plasma apolipoprotein B levels and cholesterol indices among patients receiving statins and nonstatin treatment: Post-hoc analyses from the U.K. InPractice study
Iskandar Idris et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement
John H. Contois et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
Metabolites and tissue distribution of resveratrol in the pig
Maria Azorin-Ortuno et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure
R. H. X. Wong et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
Ole Vang et al.
PLOS ONE (2011)
The Dynamics of Oxidized LDL during Atherogenesis
Hiroyuki Itabe et al.
JOURNAL OF LIPIDS (2011)
ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
EUROPEAN HEART JOURNAL (2011)
Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk
Robert S. Rosenson et al.
ATHEROSCLEROSIS (2010)
Support of drug therapy using functional foods and dietary supplements: focus on statin therapy
Simone Eussen et al.
BRITISH JOURNAL OF NUTRITION (2010)
Effects of Low-Dose Simvastatin on the Distribution of Plasma Cholesterol and Oxidized Low-Density Lipoprotein in Three Ultracentrifugally Separated Low-Density Lipoprotein Subfractions: 12-Month, Open-Label Trial
Yasuhiko Homma et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Role of dietary supplements in lowering low-density lipoprotein cholesterol: A review
Prabhjot S. Nijjar et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
Oxidized LDL and its correlation with lipid profile and oxidative stress biomarkers in young healthy Spanish subjects
Maria Isabel Burgos Alves et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2010)
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Philip Greenland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Targets of Statin Therapy: LDL Cholesterol, Non-HDL Cholesterol, and Apoliproprotein B in Type 2 Diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)
Valentine Charlton-Menys et al.
CLINICAL CHEMISTRY (2009)
Effect of a Low Dose of Dietary Resveratrol on Colon Microbiota, Inflammation and Tissue Damage in a DSS-Induced Colitis Rat Model
Mar Larrosa et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)
Meta-Analysis of the Relationship Between Non-High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
Jennifer G. Robinson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters
Il Jin Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population:: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort
Raul Zamora-Ros et al.
BRITISH JOURNAL OF NUTRITION (2008)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Ian Graham et al.
EUROPEAN HEART JOURNAL (2007)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
A new process to develop a cocoa powder with higher flavonoid monomer content and enhanced bioavailability in healthy humans
Francisco A. Tomas-Barberan et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat
Suresh Varma Penumathsa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine
Ulrik Stervbo et al.
FOOD CHEMISTRY (2007)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis
JF Navarro et al.
NEPHRON CLINICAL PRACTICE (2003)
Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study)
V Sigurdardottir et al.
JOURNAL OF INTERNAL MEDICINE (2002)
Postharvest stilbene-enrichment of red and white table grape varieties using UV-C irradiation pulses
E Cantos et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)
Oxidized LDL in carotid plaques and plasma associates with plaque instability
K Nishi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update - Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases
TA Pearson et al.
CIRCULATION (2002)
Share Paper
